Look-back, interfaces and bedside safeguards
15 min
Skills you'll build4 skills
- Trace implicated components after a transfusion-transmitted infection report
- Stop release when an interface converts a blank or invalid screen to negative
- State the bedside identity check and administration rules for a component
- Decide crossmatch or type and screen for a surgery from the blood order schedule
At the bench: Perform and document the laboratory workup of a transfusion reaction
Try first
Get the idea
Use the explanation to check your first decision.
Look-back
When a donation tests repeatedly reactive for HBV, HCV, HIV or HTLV, every earlier donation from that donor becomes suspect. The collecting facility notifies each hospital that received earlier components.1 The transfusion service then:
- Quarantines any earlier component still in date, pending supplemental testing.
- Finds the recipients of the earlier components that were transfused.
- Follows its procedure for notifying the recipient's physician if the infection is confirmed.1
When a recipient develops an infection that might have come from a transfusion, the transfusion service notifies the collecting facility promptly. Proof that a donor transmitted it is not needed first.2
LIS interfaces
An interface transfers analyzer results into the laboratory information system (LIS). One that maps a blank or invalid antibody screen to "negative" creates a result the analyzer never produced. That false negative can pass the electronic crossmatch check and release units without an antibody investigation.1,3 Only an explicit, valid final result code completes a screen. A blank, invalid or unknown code shows as unresolved and keeps its analyzer flag. Under the laboratory's rules, an unresolved screen is ineligible for electronic crossmatch.3
Bedside identification and administration
Identity is checked at collection, at testing, at issue and at the bedside. Immediately before infusion, at the patient, the final check matches the patient's identifiers, the unit label and the compatibility record. Bedside clerical error remains the leading preventable cause of fatal ABO-incompatible transfusion.1,4
| Administration rule | Reason |
|---|---|
| Only 0.9% sodium chloride runs with the component | Other solutions lack compatibility data |
| No dextrose solutions in the line | Dextrose hemolyzes red cells |
| No calcium solutions, such as lactated Ringer's | Calcium reverses the citrate and clots the line |
| A standard 150- to 260-micron filter | It removes clots and aggregates |
| Finish within 4 hours of entering the container | Longer at room temperature increases the risk of bacterial growth |
Ordering for surgery
Most operations need no transfusion. A maximum surgical blood order schedule (MSBOS), built from the facility's own transfusion data, lists which procedures get crossmatched units and which get a type and screen only. With a type-and-screen policy, it keeps the crossmatch-to-transfusion ratio near 2:1 to 3:1. It also saves inventory and testing time for patients with antibodies.1
Follow the bench demonstration
Sources for this step
References
- Bloch EM, Campbell-Lee S, McKenna DH Jr, Montemayor-Garcia C, Schwartz J, Shaz B, Storry J, eds. Technical Manual. 22nd ed. AABB; 2026.
- Centers for Disease Control and Prevention. National Healthcare Safety Network. Biovigilance Component Hemovigilance Module Protocol. Version 3.0. January 2026. Accessed September 27, 2026.
- US Food and Drug Administration. Blood Establishment Computer System Validation in the User's Facility: Guidance for Industry. April 2013. Accessed September 27, 2026.
- Association for the Advancement of Blood & Biotherapies, American Red Cross, America's Blood Centers, Armed Services Blood Program. Circular of Information for the Use of Human Blood and Blood Components. June 2024. Accessed September 27, 2026.
Watch one
Read each decision and its explanation.
At 02:10 the operating room asks for 2 red-cell units for Farid Glass, 61 (MRN 6620194). The LIS shows his antibody screen as Negative and marks him eligible for electronic crossmatch. The interface from the antibody-screen analyzer was replaced this week.
What do you do before issuing units?
- Open the analyzer's record for his specimen. It shows an invalid flag and a blank interpretation field.
The analyzer record shows the original result. The LIS shows the result after interface mapping.
- Treat the screen as unresolved.
A blank field is not an interpretation. Only an explicit, valid final result code completes a screen.
- Remove his electronic crossmatch eligibility, and issue no units on this screen.
An unresolved screen cannot show that he lacks clinically significant antibodies.
- Repeat the antibody screen on his specimen.
A valid result determines the next step: an electronic crossmatch, or an antibody investigation.
- Report the fault to the supervisor as a nonconformance.
The same mapping handles every screen, so other results sent since the change may have the same error.
Your turn
Use it
Read the case evidence, then make each decision. The step is complete without it.
- Northfield Blood Center calls your transfusion service.
- A regular donor's latest donation is repeatedly reactive for anti-HCV. Supplemental testing is pending.
- The same donor gave blood 4 months ago. Your hospital received that donation's red cells and frozen plasma.
- The red cells were transfused 3 months ago to Walter Piper, 74 (MRN 3307821), a retired ferry captain.
- The plasma is still in your freezer and in date.
The earlier donation still had in-date plasma in the freezer. A nonreactive test at collection can fall in an infection's window period, so today's reactive result makes the older donation suspect. Quarantine prevents the plasma from being issued, and the transfusion record identifies who received the red cells.
Review missed questions
For reference
Sources checked